It has been demonstrated that different Ki-67 expression levels can predict the prognosis of patients with hepatitis B-related HCC and can also predict the efficacy of hepatectomy in patients with MVI and cancers in different Barcelona stages (8, 9). This evidence concerns the gene MKI67 and hepatocellular carcinoma.